Table 5. Sites of Bleeding Found During 1-Year Follow-Up.
| Total no. of pts (n = 98) | TT (n = 48) | DT (n = 31) | DAPT (n = 19) | P-value | |
|---|---|---|---|---|---|
| Bleeding events (major and minor) | 18 (18.4%) | 8 (16.66%) | 6 (19.35%) | 4 (21%) | 0.903 |
| Major bleeding events | |||||
| Total | 7 (7.1%) | 4 (8.3%) | 2 (6.45%) | 1 (5.2%) | 0.893 |
| Intracranial | 2 (2.04%) | 1 (2.1%) | 1 (3.2%) | 0 | 0.735 |
| Gastrointestinal | 2 (2.04%) | 1 (2.1%) | 1 (3.2%) | 0 | 0.735 |
| Genitourinary | 2 (2.04%) | 1 (2.1%) | 0 | 1 (5.2%) | 0.442 |
| Other (iliopsoas hematoma) | 1 (1.02%) | 1 (2.1%) | 0 | 0 | 0.591 |
| Minor bleeding events | |||||
| Total | 11 (11.33%) | 4 (8.3%) | 4 (12.9%) | 3 (15.8%) | 0.642 |
| Nose | 7 (7.1%) | 4 (8.3%) | 3 (9.6%) | 0 | 0.394 |
| Genitourinary | 4 (4.1%) | 0 | 1 (3.2%) | 3 (15.8%) | 0.013 |
| Relapses of minor bleeding | |||||
| Minor bleeding events > 1 in the same patient | 8 (8.16%) | 5 (10.4) | 2 (6.45%) | 1 (5.26%) | 0.719 |
Data are reported as number (percentage). pts: patients; TT: triple therapy (warfarin + acid acetylsalicylic acid and clopidogrel); DT: dual therapy (warfarin + acid acetylsalicylic or clopidogrel); DAPT: dual antiplatelet therapy (acetylsalicylic acid + clopidogrel).